# A Study in Healthy Male Subjects Designed to Assess the Mass Balance Recovery and Pharmacokinetics of 14C TZP-101

> **NCT01668199** · PHASE1 · COMPLETED · sponsor: **Norgine** · enrollment: 6 (actual)

## Conditions studied

- Postoperative Ileus

## Interventions

- **DRUG:** TZP-101

## Key facts

- **NCT ID:** NCT01668199
- **Lead sponsor:** Norgine
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-02
- **Primary completion:** 2012-02
- **Final completion:** 2012-03
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2012-08-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01668199

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01668199, "A Study in Healthy Male Subjects Designed to Assess the Mass Balance Recovery and Pharmacokinetics of 14C TZP-101". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01668199. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*